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Abstract:  Type 2 diabetes mellitus (DM) is associated with increased risk of endothelial dys-
function if it lasts a long time without control. This study aims to connect the Onset of  Diabetes 
Mellitus (DM) with Nitric Oxide levels in patients of type 2 diabetes mellitus. The study used 
cross-sectional study method. The samples were 86 subjects, consisting of 38 subjects of Type 
2 DM controlled  and 48 subjects of Type 2 DM uncontrolled. The results of the Kruskal-Wallis 
statistical test showed no significant difference between the Onset of  DM and Nitric Oxide lev-
els in the categories of 4-6 years (19.4 ± 10.1), 7-9 years (17.3 ± 9.3) and 10-12 years (13.3 ± 
8.5) (p=0.06). Furthermore, the Spearman correlation test revealed a negative correlation be-
tween the Onset of DM and Nitric Oxide level in patients with Type 2 DM with and without con-
trol (r =-0.217). The level of Nitric Oxide (NO) can consider as a predictor of long-term compli-
cation in patients with type 2 DM.     
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INTRODUCTION 
The World Health Organization (WHO) 
defines diabetes mellitus as a collection of an-
atomical and chemical problems that result 
from some factors in which there is absolute or 
relative insulin deficiency and impaired insulin 
function associated with accelerated athero-
sclerosis and predisposes to specific micro-
vascular abnormalities such as occurrence ret-
inopathy, nephropathy, and neuropathy.  dia-
betes mellitus Is related to increasing life ex-
pectancy, lifestyle, less physical activity and a 
disproportionate diet (Sugiono, 2007). 
Prolonged hyperglycemia and insulin 
resistance experienced by people with diabe-
tes mellitus (DM) will lead to increased polyol 
pathway activity in this case sorbitol, increased 
synthesis of Advanced Glycosylation End 
Products (AGEs), activation of Protein Kinase 
C (CCP) and cytokine release by adipose tis-
sue. The activity of these various cellular path-
ways will lead to physiological disorders and 
damage to vascular endothelium (Beckmen, 
2008). Endothelial dysfunction is defined as an 
imbalance between relaxation and contraction 
factors, between procoagulant mediators and 
anticoagulants or between substances that in-
hibit and promote growth (Personal et al., 
2008). 
Changes in endothelial function in pa-
tients with DM has widely proven both invitro 
and invivo. Research by Jansson et al (2009), 
in patients with coronary heart disease (CHD) 
occurs endothelial dysfunction characterized 
by an increase in the production of various 
compounds that are prothrombotic and vaso-
constriction such as Tissue Factor (TF), Von 
Willebrand Factor (vWF), Platelet Activation 
Factor (PAF), endothelin, Thromboxane A2, 
Plasminogen Activator Inhibitor-1 (PAI-1). Sim-
ilarly, studies conducted by Widiastuti (2012), 
in patients with CHD and without diabetes 
mellitus showed a decline in the production of 
antithrombotic compounds and vasodilatations 
such as Nitric Oxide (NO), thrombomodulin, 
and Tissue Plasminogen Activator (TPA). Pre-
sumably the role of NO in the process of CHD 
occurrence due to atherosclerosis through the 
mechanism of endothelial dysfunction, where 
NO is an important mediator that can act as 
free radicals and can turn into peroxynitrite 
formed by neuronal cells that modulate neuro-
transmission in endothelial cells and stimulate 
the relaxation/dilatation of blood vessels.  
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Decreased NO levels occur due to de-
creased NO synthesis or increased degrada-
tion resulting in superoxide anion production 
resulting in decreased inhibition of atherogenic 
and thrombogenic processes and decreased 
the ability of coronary artery dilatation (Zieman 
SJ, 2008). Although the study by Kumar V et 
al., 2009 shows that there is an increase in 
NO levels in CHD patients but on the other 
hand some experts argue that NO levels play 
a role as a marker of endothelial dysfunction 
and are not independent coronary risk factors 
(Paul W et al., 2011). 
People with diabetes are expected to 
conduct regular tests and treatments to moni-
tor their metabolic status, as a guideline for 
monitoring controlled DM therapy if HbA1c 
levels <7%. According to The Diabetes Con-
trol and Complications Trial (DCCT), the pres-
ence of good glycemic control can slow the 
development of early complications of diabe-
tes, one of which is endothelial dysfunction 
characterized by a decrease in the value of 
nitric oxide (NO) (McPhee, 2010). Research 
conducted by Erick et al. (2007), showed that 
low HbA1c in patients with DM have a low risk 
of occurrence of microvascular complications. 
Research on levels of NO in patients 
with DM by onset is not yet fully the attention 
of researchers. Whereas long-term hypergly-
cemia affects endothelial function with the ac-
tivation of various pathways both sorbitol, AG-
Es, and PKC which leads to decreased NO 
role as a potent vasodilator or NO in the form 
of Endothelial Nitric Oxide System (eNOS) 
which functions as anti-inflammatory and anti-
thrombosis (Chan N, 2008). Therefore, this 
study aims to link the onset of diabetes melli-
tus with nitric oxide levels in patients with type 
2 diabetes mellitus. 
 
MATERIAL AND METHOD 
This research is one of the competen-
cies of medical laboratory technology in the 
field of clinical chemistry. This type of analysis 
is analytical research using Cross-Sectional 
design. The study was conducted from July to 
November 2016 at the Clinical Pathology La-
boratory of Hasanuddin University Hospital 
(RSUH) Makassar. 
The samples of this study were adults, 
men and women who came to  Hasanuddin 
University Hospital (RSUH), Makassar and 
diagnosed with Type 2 DM by the clinician.  
Willing to check Nitric Oxide (NO) and meet 
the criteria inclusion is not taking anticoagu-
lant / antiplatelet drugs (eg.heparin) as well as 
antioxidants such as vitamin C, not acute / 
chronic infections characterized by Blood 
Endapode (LED) <15 mm / h for men and <20 
mm / h for women, diabetic ulcers, history of 
stroke and other cerebrovascular diseases, 
pregnancy. 
The patient's venous blood has been 
taken three ccs using a vacutainer and Sepa-
rating Tube (SST) serum tube, the separator 
gel contained in the SST tube will speed up 
the serum separation process from the blood 
cells when centrifuged at 3000 rpm for 10 
minutes. 
Measurements of HbA1c levels have 
made by inserting 500 μl serum samples into 
the HbA1c cassette. Total Hb is measured col-
orimetrically. NO levels have been determined 
using a spectrophotometric method with 
Griess reaction principle, i.e., NO examination 
by way of indirectly by spectrophotometric. 
This examination involves the enzymatic con-
version of nitrate to nitrite, by the enzyme Ni-
trate Reductase, followed by the colorimetric 
detection of nitrite as a dye-colored azo dye 
product of a Griess reaction absorbing 540 nm 
visible light.  
To see the difference of Nitric Oxide 
content in the three categories of DM Old (4-6 
years, 7-9 years and 10-12 years) analyzed by 
Kruskal Wallis Test because the data was not 
abnormal distributed and for Old DM 
Correlation Test with Nitric Oxide content was 
analyzed with Spearman Correlation Test. For 
other data analysis using categorical variables 
done with the Descriptive test. The results of a 
study are said to be significant when the value 
of p <0.05.  
 
RESULTS AND DISCUSSION 
Characteristics of the sample 
The number of samples that 
participated in the study was 86 samples 
consisting divided into several categories: 
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After the Kruskal-wallis test (p = 0.06) it 
can be said there is no significant difference 
between Onset DM of each category with Ni-
tric Oxide content. 
 
Table 2.Comparison of DM Onset to NO  








Spearman correlation test results also 
indicate negative correlation (r = -0.217) be-
tween Onset DM and Nitric Oxide (NO) level in 
Patient DM Type 2 but have weak correlation 
strength. 
 
Table 3. Correlation between Onset of DM and 








The age range of DM Type 2 subjects in 
this study was 40-75 years (table 1). Other 
studies have revealed the same thing, Ananta 
et al. (2000), discloses similarly, that generally, 
Type 2 DM occurs after the 4th decade. Wild 
et al. (2004), in his article, mentions that the 
estimated number of diabetic subjects in 2030 
will increase and the largest age group re-
mains between 40-70 years, both in develop-
ing countries and around the world. Research 
conducted Handayani et al. (2003), in Sema-
rang concluded that the age of more than 45 
years has a risk of having type 2 diabetes by 
7.5 times compared with those aged less than 
45 years. As already known, there are three 
critical factors related to DM pathogenesis: (1) 
genetic factors, (2) pancreatic beta cell disor-
ders, and (3) decreased insulin activity in insu-
lin-sensitive tissues, including skeletal muscle, 
liver, and fat mass. Insulin resistance in Type 2 
DM is not very clear, but the following factors 
play a significant role: obesity, low-fat carbohy-
drate and low physical activity that are com-
mon in 40-year-olds, a risk factor for Type 2 
DM. 
 The number of DM Type 2 subjects not 
controlled more than the controls. This condi-
tion thus gives the impression of high-risk fac-
tors for the development of diabetes complica-
tions. This is as reported by Kilpatrik et al. 
(2007), strictly controlled DM patients less de-
veloped toward complications. The controlled 
and uncontrolled Group 2 DM divided by 
HbA1c levels by Perkeni (2011), defined ≤7% 
controlled category and> 7% in the open cate-
gory. Use of HbA1c in diabetes to monitor long
-term blood glucose, so as to predict the devel-
opment and progression of microvascular 
complications. Uncontrolled diabetes mellitus 
will increase free fatty acids and insulin re-
sistance resulting in endothelial dysfunction 
with inhibition of nitric oxide synthesis (NO) or 
increase NO catabolism. Insulin increases the 
activity of nitric oxide system (NOS) by stimu-
lating phosphotidylinositol-3 kinase and Akt 
kinase. Signal transduction with insulin via the 
phosphotidylinositol-3 kinase pathway in insu-
lin resistance patients is impaired. Insulin stim-
ulates NOS to be less and NO production de-
creases, resulting in more endothelin produced 
and an increase in inflammation and throm-
bosis (Sargowo D, Rohman S, 2008).  
 Duration of DM in this study divided into 
3 groups of category 4-6 years 25 people with 
average rate of 19.4 ± 10.1, 7-9 years old as 
many as 37 people with the average price of 
NO 17.3 ± 9.3, and 10 -12 years as many as 
23 people with a mean of NO 13.3 ± 8.5. 
There was a significant difference between 
each group of Old category of DM to NO (p = 
0.06), but weak correlation strength (r = -
0.217) (table 2 and table 3). Previous studies 
conducted by Widiastuti et al. (2012) in CHD 
subjects with and without Type 2 DM showed 
that CHD subjects with DM had a lower NO 
value. NO levels, in theory, correlate with the 
incidence of endothelial dysfunction.  
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NO has three isoenzymes; two of which 
strictly related to the rate of thrombosis. Isoen-
zymeeNOS (endothelial nitric oxide synthase) 
expressed by both platelet cells and endotheli-
al cells, but quantitatively derived from endo-
thelial cells is much greater. IsoenzymeeNOS 
is essential in the regulation of platelet function 
(release of substance) to determine the physi-
ological and thrombotic balance, while iOSiso-
enzymes (inducible nitric oxide synthase) have 
remodeling effects on blood vessels (Chan. et 
al., 2012). It's just because of limitations and 
technical reasons; these two isoenzymes can-
not be analytical researchers, so only NO total 
studied in this study. 
 
CONCLUSION 
There was no significant difference be-
tween Onset DM and Nitric Oxide (NO) levels 
for each category (p = 0.06), and there was a 
negative correlation between DM onset and 
Nitric Oxide (NO) level in patients with Type 2 
DM but correlated strength the weak (r = -
0.217). Nitric Oxide (NO) content may be con-
sidered a predictor of long-term complications 
in patients with type 2 DM. 
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